Mikkel Anbo

Mikkel Anbo is a Postdoctoral Researcher at the National Food Institute, Technical University of Denmark (DTU), specializing in genomic epidemiology within the Research Group for Genomic Epidemiology. His work focuses on high-risk clones of Pseudomonas aeruginosa, particularly ST111, examining serotype switching mechanisms and antimicrobial resistance evolution.

His research interests center on genomic epidemiology of bacterial pathogens, with specific expertise in Pseudomonas aeruginosa virulence mechanisms, whole-genome sequencing analysis, and high-risk clone surveillance. Key areas include O-antigen variation, serotype switching dynamics, and the genomic basis of antibiotic resistance in clinical isolates. His work contributes to UN Sustainable Development Goals related to health security and disease prevention.

Analysis of his recent publications reveals consistent focus on ST111 clone evolution across global settings (France, China), with emphasis on genomic drivers of virulence and resistance. His 2024 PLOS Pathogens paper demonstrates how serotype switching enhances bacterial adhesion, while earlier work established detection methods for these switching events.

His doctoral project "Preventing Emergence of antibiotic resistant 'high-risk clones' of Pseudomonas aeruginosa" (2019-2023) was supervised by Professor Lea Jelsbak, indicating strong institutional support for his research trajectory. Current work continues this line through postdoctoral research at DTU's National Food Institute.

The Research Group for Genomic Epidemiology at DTU's National Food Institute provides his primary laboratory environment, with international collaborations evident in publications spanning French hospitals and Guangdong, China. His work integrates clinical microbiology with advanced genomic analysis to address antimicrobial resistance threats.